Association of HaeIII single nucleotide polymorphisms in the SLC2A1 gene with risk of diabetic nephropathy; evidence from Kurdish patients with type 2 diabetes mellitus

QJM : Monthly Journal of the Association of Physicians
Sabrieh AminiMohammad Abdi

Abstract

Given the growing rate of patients with type 2 diabetes mellitus, uncovering the effects of gene polymorphism on diabetes pathogenesis has attracted a lot of attention. Because glucose transporter 1 is involved in glucose uptake, the polymorphism of this gene may be an important risk factor in type 2 diabetes mellitus or in the progression of diabetes complications such as diabetic nephropathy. As far as the authors are concerned, this study is the first one aiming at evaluating the probable effects of solute carrier family 2 facilitated glucose transporter member 1 (SLC2A1) HaeIII polymorphism on clinical and laboratory outcomes of Kurdish patients with type 2 diabetes mellitus. This study was conducted involving 126 diabetic nephropathy patients and 150 diabetic patients without renal involvement. Serum levels of Cystatin C, fasting blood glucose, creatinine and urinary albumin; levels of glycated hemoglobin and estimated glomerular filtration rate were measured. Moreover, the Hae III polymorphism of SLC2A1 gene was determined by PCR-restriction fragment length polymorphism (RFLP). The rate of CC genotype was higher (37%) in patients with diabetic nephropathy compared with controls. There were a significant correlation betwee...Continue Reading

References

Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J J ChinC Y Jung
Sep 6, 1985·Science·M MuecklerH F Lodish
Oct 1, 1984·The Journal of Clinical Investigation·S M MauerF C Goetz
Dec 26, 2001·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·B D'Agord SchaanH Schmid
Feb 18, 2005·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Frank C Brosius, Charles W Heilig
Sep 28, 2006·The European Journal of General Practice·Joan G M DeckersDouglas M Fleming
May 30, 2007·Archives of Internal Medicine·Peter W F WilsonRalph B D'Agostino
Jul 10, 2008·Diabetes/metabolism Research and Reviews·K MakniH Ayadi
Oct 28, 2008·Trends in Genetics : TIG·Inga ProkopenkoCecilia M Lindgren
Dec 19, 2008·Diabetes Research and Clinical Practice·Masoud Amini, Ehsan Parvaresh
Apr 21, 2012·Diabetes Care·William H Herman, Paul Zimmet
Jul 12, 2012·Journal of Diabetes·Weihui YuWeiping Jia
Aug 15, 2012·Eastern Mediterranean Health Journal = La Revue De Santé De La Méditerranée Orientale = Al-Majallah Al-ṣiḥḥīyah Li-sharq Al-mutawassiṭ·S BonakdaranM Khajeh-Dalouie
Jul 23, 2013·Journal of Diabetes and Its Complications·Stavroula PapaoikonomouChristodoulos Stefanadis
Dec 4, 2014·Biomedical Reports·Fumitaka TokoroYoshiji Yamada
Feb 24, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·T MarquesM L Corrêa-Giannella

❮ Previous
Next ❯

Citations

Nov 23, 2017·QJM : Monthly Journal of the Association of Physicians·R Nasiri-KalmarziZ Vahabzadeh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Farzad MaroofiMohammad Abdi
Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i
A ArtenieI Haulică
© 2021 Meta ULC. All rights reserved